Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,154 | 26,120 | 43,108 | 13,601 | 25,574 |
| Receivables | 3,797 | 3,658 | 3,880 | 1,500 | 2,292 |
| Inventories | 12,247 | 12,439 | 12,628 | 13,419 | 13,151 |
| Other current assets | 0 | 1,500 | 1,500 | 845 | 845 |
| TOTAL | $73,630 | $46,420 | $62,342 | $31,444 | $44,271 |
| Non-Current Assets | |||||
| PPE Net | 30,337 | 30,616 | 30,467 | 29,756 | 28,627 |
| Intangibles | 7,956 | 8,168 | 8,379 | 9,267 | 9,541 |
| Other Non-Current Assets | 5,829 | 5,935 | 6,832 | 2,347 | 2,201 |
| TOTAL | $44,123 | $44,718 | $45,677 | $41,369 | $40,368 |
| Total Assets | $117,752 | $91,138 | $108,019 | $72,814 | $84,639 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 29 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,101 | 5,718 | 5,921 | 9,156 | 4,672 |
| Accrued Expenses | 3,644 | 3,582 | 3,377 | 3,860 | 4,144 |
| Other current liabilities | N/A | N/A | N/A | 177 | 17 |
| TOTAL | $6,917 | $9,443 | $9,440 | $13,339 | $15,645 |
| Non-Current Liabilities | |||||
| Long Term Debt | 40,870 | 40,467 | 40,211 | 29,369 | 24,188 |
| Deferred Revenues | 143 | 143 | 143 | 145 | 145 |
| Other Non-Current Liabilities | 15,730 | 15,691 | 15,488 | 14,530 | 14,506 |
| TOTAL | $59,076 | $58,669 | $58,246 | $46,482 | $41,312 |
| Total Liabilities | $65,993 | $68,112 | $67,686 | $59,821 | $56,957 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,350 | 36,726 | 45,317 | 25,793 | 25,793 |
| Common Shares | 5 | 5 | 5 | 3 | 1 |
| Retained earnings | -183,264 | -168,516 | -150,694 | -137,711 | -122,508 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 2 |
| TOTAL | $51,759 | $23,025 | $40,333 | $12,993 | $27,682 |
| Total Liabilities And Equity | $117,752 | $91,138 | $108,019 | $72,814 | $84,639 |